A model for adopting proton therapy
Although proton therapy was historically available for major academic institutions, Shreveport has become a model for how community hospitals can adopt this advanced treatment. Dr. Rosen emphasizes that implementing a proton therapy program has become entirely feasible with the right resources, physics support, and hospital backing. The outcomes for suitable cancer patients are notable, including reduced side effects, more tolerability, and potentially faster treatment courses.1,2 As reported after the installation of ProteusONE, the Willis Knighton Cancer Center was the first to announce a record mean time in the treatment room of 16 minutes per patient achieved with the single room Proteus®ONE solution.2
ProteusONE’s halo effect
A significant phenomenon observed after introducing the ProteusONE system is the "halo effect", which refers to an increase in patient referrals. Early on, the center experienced a surge in referrals from competing institutions and centers that would not usually refer patients to Shreveport, but also increased self-referrals from patients eager to access this innovative technology. Dr. Rosen notes that patients are increasingly aware of proton therapy's advantages, prompting them to seek treatment options in hospitals that provide it. This growing demand for proton therapy underscores the need for larger institutions to consider adopting this advanced cancer treatment technology to meet patient needs.
Find out more about ProteusONE’s halo effect here.
Unique features of the ProteusONE system
One of the key reasons the ProteusONE system can treat various indications is its compact design and advanced features. Unlike traditional systems, ProteusONE includes a robotic couch, an open gantry enabling the treatment of complicated brain tumors using a vertex beam. The speed and precision of the treatment, as well as the dosimetry resulting from its small spot size, allow for effective treatment plans for patients who would otherwise be candidates for IMRT.
Find out more about IBA’s unequaled expertise and ProteusONE's unmatched versatility here.
Partnership with IBA, leader in proton therapy
Dr. Rosen highlights the collaboration with IBA, the world leader in proton therapy. Initially, the center evaluated multiple vendors before switching to IBA, seeking a partner with the expertise, research capabilities, and support necessary for a successful proton therapy program. The presence of IBA professionals at the cancer center has proven invaluable, fostering a sense of family and collaboration that enhances patient care. Their presence ensures rapid intervention in case of issues with a patient’s treatment, with the machine or the technology resulting in one of the highest uptimes of any proton therapy machine worldwide.
Discover IBA’s on-site and remote support and intelligent maintenance program here.
Cancer patient experience and new standards of care
Receiving proton therapy in the ProteusONE system feels similar to traditional treatments in a linear accelerator vault. The compact design and comforting environment, brought by the Phillips Ambient Experience, including ambient lighting, music, and videos, contribute to a positive patient experience. Dr. Rosen mentions that patients appreciate knowing they are receiving the most advanced therapy available, which boosts their comfort and confidence in the treatment process.
The introduction of proton therapy has transformed the cancer center's operations and elevated the overall quality of care. Dr. Rosen asserts that the partnership with IBA has been perfect, providing ongoing support and expertise since the program's inception. The ProteusONE was designed with centers like theirs in mind, making it an ideal fit for the community hospital setting.
In conclusion, the successful implementation of the ProteusONE proton therapy system in a Community Hospital like the Willis Knighton Cancer Center serves as a model for others. With the right resources, support, and technology, community hospitals can provide advanced cancer care that benefits patients and meets growing demands. As more institutions recognize the value of proton therapy, the landscape of cancer treatment will continue to evolve. IBA is committed to helping hospitals make proton therapy accessible to every patient who could benefit from it.
References:
- Mohan, R. et al. Proton therapy – Present and future. Adv Drug Deliv Rev. 2017;10926–44. DOI: 10.1016/j.addr.2016.11.006
- IBA Press Release. Willis-Knighton Proton Therapy Center reports a record mean
- treatment time of 16 minutes per patient. October 20, 2018. Available at: https://www.iba-worldwide.com/sites/default/files/2023-05/willisknighton_18oct_final.pdf
Notes
Disclaimer: The statements of the healthcare professional included in this testimonial reflect only his opinion and personal experience. They do not necessarily reflect the opinion of any institution with whom he is affiliated or IBA.
